CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Senseonics Holdings, Inc. - SENS CFD

0.8488
2.14%
Market Trading Hours* (UTC) Opens on Tuesday at 14:30

Tue - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0086
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.8674
Open 0.8906
1-Year Change 78.41%
Day's Range 0.7962 - 0.8906
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 0.8488 -0.0197 -2.27% 0.8685 0.9284 0.7864
Jan 16, 2025 0.8674 0.1712 24.59% 0.6962 0.9060 0.6892
Jan 15, 2025 0.7170 -0.0071 -0.98% 0.7241 0.7347 0.6691
Jan 14, 2025 0.7347 -0.0244 -3.21% 0.7591 0.7955 0.7091
Jan 13, 2025 0.7336 -0.0086 -1.16% 0.7422 0.8047 0.6645
Jan 10, 2025 0.7406 0.2441 49.16% 0.4965 0.8273 0.4691
Jan 8, 2025 0.4218 -0.0460 -9.83% 0.4678 0.4678 0.4218
Jan 7, 2025 0.4691 0.0094 2.04% 0.4597 0.5103 0.4597
Jan 6, 2025 0.4608 -0.0364 -7.32% 0.4972 0.5218 0.4505
Jan 3, 2025 0.4991 0.0317 6.78% 0.4674 0.5080 0.4674
Jan 2, 2025 0.4721 -0.0403 -7.86% 0.5124 0.5131 0.4611
Dec 31, 2024 0.4998 -0.0263 -5.00% 0.5261 0.5393 0.4742
Dec 30, 2024 0.5361 0.0170 3.27% 0.5191 0.5837 0.4917
Dec 27, 2024 0.5773 -0.0489 -7.81% 0.6262 0.6891 0.5591
Dec 26, 2024 0.5760 0.1020 21.52% 0.4740 0.5958 0.4591
Dec 24, 2024 0.4702 0.0026 0.56% 0.4676 0.4825 0.4497
Dec 23, 2024 0.4659 -0.0097 -2.04% 0.4756 0.4837 0.4591
Dec 20, 2024 0.4642 0.0351 8.18% 0.4291 0.4914 0.4181
Dec 19, 2024 0.4454 0.0283 6.78% 0.4171 0.4561 0.3991
Dec 18, 2024 0.4005 -0.0006 -0.15% 0.4011 0.4471 0.3941

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Senseonics Holdings, Inc. Company profile

Senseonics Holdings is a medical technology company that develops and manufactures continuous glucose monitoring (CGM) systems, specialising in long-term, implantable CGM systems for diabetes patients. It was founded in 1996 and trades on the New York Stock Exchange (NYSE) under the ticker SENS.

Headquartered in Maryland, US, the company had its initial public offering (IPO) in 2016, with an underwritten public offering of 15,800,000 shares of its common stock at $2.85 a share. Leerink Partners LLC and Canaccord Genuity acted as joint book-running managers for the offering, with Raymond James & Associates as lead manager and BTIG LLC as co-manager.

In February 2022, Senseonics’ Eversense E3 Continuous Glucose Monitoring System, touted as the first and only such CGM system, was approved for use for up to six months by the US Food and Drug Administration (FDA). The technology was reported to be available to patients in the US by the second quarter of 2022 through Senseonics’ global commercial partner, Ascensia Diabetes Care

The company’s partnership with Ascencia began in August 2020, when the pair announced a collaboration and commercialisation agreement that made Ascencia the sole distributor of Senseonics’ Eversense CGM systems worldwide. At that same time, Seseonics announced a financing agreement with Ascencia’s parent company, Masters Special Situations. The two agreements collectively made for $80m of debt and equity capital.

Industry: Medical Equipment, Supplies & Distribution (NEC)

20451 Seneca Meadows Pkwy
GERMANTOWN
MARYLAND 20876-7005
US

People also watch

ETH/USD

3,294.27 Price
-5.220% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

BTC/USD

102,841.45 Price
-1.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

3.10 Price
-5.720% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01547

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading